BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25091478)

  • 61. Are the specific and nonspecific ANA staining patterns of Behçet's Disease patients important?
    Ilhan F; Aksoy R; Tutkak H
    Reumatol Clin (Engl Ed); 2022 Mar; 18(3):147-149. PubMed ID: 35277212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased solubilization of immune complexes by the sera from patients with Behcet's disease.
    Tanaka K; Kajiyama K; Kameda S; Nishigouri S; Yamada I; Sawae Y
    Tohoku J Exp Med; 1983 Aug; 140(4):363-8. PubMed ID: 6636135
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prohibitin as a novel autoantigen in rheumatoid arthritis.
    Shi LL; Chen P; Xun YP; Yang WK; Yang CH; Chen GY; Du HW
    Cent Eur J Immunol; 2015; 40(1):78-82. PubMed ID: 26155187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Behcet's disease and pregnancy-a case report and literature review.
    Xu C; Bao S
    Am J Reprod Immunol; 2017 Jan; 77(1):. PubMed ID: 27296674
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Moesin expression is correlated with its involvement in patients with Behcet's disease.
    Hussain M; Chen P; Zhang Y; Tian Y; Du H
    Arch Med Sci; 2020; 16(4):924-930. PubMed ID: 32542096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autoimmunity to S-antigen and retinal vasculitis in patients with Behçet's disease.
    Ermakova NA; Alekberova ZS; Prokaeva TB
    Adv Exp Med Biol; 2003; 528():279-81. PubMed ID: 12918707
    [No Abstract]   [Full Text] [Related]  

  • 67. Are the Specific and Nonspecific ANA Staining Patterns of Behçet's Disease Patients Important?
    Ilhan F; Aksoy R; Tutkak H
    Reumatol Clin (Engl Ed); 2020 Dec; ():. PubMed ID: 33386246
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comprehensive exploration of autoantibody in Behçet's disease: a novel autoantibody to claudin-1, an essential protein for tight junctions, is identified.
    Morishima A; Hirano T; Nishikawa H; Nakai K; Sakaguchi S; Kumanogoh A
    Joint Bone Spine; 2014 Dec; 81(6):546-8. PubMed ID: 24792642
    [No Abstract]   [Full Text] [Related]  

  • 69. Induction of p53 in keratinocyte cultures treated with Behçet's patient sera.
    Houacine S; Kang A; Parkinson EK; Wan H; Fortune F
    J Oral Pathol Med; 2020 May; 49(5):435-442. PubMed ID: 32060959
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Serum secretory IgA level in patients with Behçet's disease].
    Nio T; Sunakawa M; Ohshio G; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1988 Nov; 92(11):1740-3. PubMed ID: 3228023
    [No Abstract]   [Full Text] [Related]  

  • 71. [Anticardiolipin antibodies in Behçet's disease].
    Hamza M; Meyer O
    Presse Med; 1986 Jul 5-12; 15(27):1281. PubMed ID: 2945185
    [No Abstract]   [Full Text] [Related]  

  • 72. Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach.
    Hu CJ; Pan JB; Song G; Wen XT; Wu ZY; Chen S; Mo WX; Zhang FC; Qian J; Zhu H; Li YZ
    Mol Cell Proteomics; 2017 Feb; 16(2):147-156. PubMed ID: 27777341
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-neutrophil cytoplasmic antibodies in Adamantiadis-Behçet's disease.
    Vaiopoulos G; Hatzinikolaou P; Tsiroyanni A; Mavropoulos S; Stamatelos G; Terzoglou K; Tzonou A; Economidou I; Kaklamanis P
    Br J Rheumatol; 1994 Apr; 33(4):406-7. PubMed ID: 8156320
    [No Abstract]   [Full Text] [Related]  

  • 74. Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
    Erdağ E; Tüzün E; Uğurel E; Cavuş F; Sehitoğlu E; Giriş M; Vural B; Eraksoy M; Akman-Demir G
    Inflamm Res; 2012 Sep; 61(9):927-30. PubMed ID: 22728961
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Behçet's syndrome and autoimmunity.
    Lehner T
    Br Med J; 1967 Feb; 1(5538):465-7. PubMed ID: 6017524
    [No Abstract]   [Full Text] [Related]  

  • 76. Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation.
    Miske R; Hahn S; Rosenkranz T; Müller M; Dettmann IM; Mindorf S; Denno Y; Brakopp S; Scharf M; Teegen B; Probst C; Melzer N; Meinck HM; Terborg C; Stöcker W; Komorowski L
    Neurol Neuroimmunol Neuroinflamm; 2016 Aug; 3(4):e255. PubMed ID: 27458598
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of heat shock protein 27 as a novel autoantigen of Behçet's disease.
    Chen P; Shi L; Jiang Y; Ji Y; Yan H; Sun S; Xun Y; Chen G; Wang X; Chen W; Du H
    Biochem Biophys Res Commun; 2015 Jan; 456(4):866-71. PubMed ID: 25529454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Behçet's syndrome: recent advances to aid diagnosis.
    Akbaba TH; Ekici M; Çolpak Aİ; Brown KL; Karadağ Ö; Balci-Peynircioglu B
    Clin Exp Med; 2023 Dec; 23(8):4079-4090. PubMed ID: 37897656
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Innate immune responses in Behçet disease and relapsing polychondritis.
    Shimizu J; Murayama MA; Mizukami Y; Arimitsu N; Takai K; Miyabe Y
    Front Med (Lausanne); 2023; 10():1055753. PubMed ID: 37435539
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review.
    Arbrile M; Radin M; Medica D; Miraglia P; Rilat L; Cecchi I; Foddai SG; Barinotti A; Menegatti E; Roccatello D; Sciascia S
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.